Our group found that miR-124 inhibited multiple targets in the signal transducer and activator of transcription 3 (STAT3) signaling pathway and reversed immune dysfunction of T cells induced by glioblastoma stem cells (GSCs) (19). The gene discussed is STAT3; the disease is glioblastoma.